MedTrace Logo

Investigating Effects in Intestinal Permeability of Rich in Beta-glucans Pleurotus Eryngii Mushrooms Fermentation Supernatants: an Ex-vivo Study

NCT05446610 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-07-06

No results posted yet for this study

Summary

The aim of the present study was to investigate the ability of Pleurotus eryngii mushrooms fermentation products (FS) to counteract induced intestinal hyperpermeability in human colonic tissues in an ex vivo system.

Conditions

  • Healthy

Interventions

OTHER

Fermented product of Pleurotus eryngii mushroom

I Stimulation of human colonic biopsies with the fermented product of Pleurotus eryngii mushroom

Sponsors & Collaborators

  • Harokopio University

    collaborator OTHER

  • Agricultural University of Athens

    collaborator OTHER

  • National Hellenic Research Foundation

    collaborator OTHER

  • Örebro University, Sweden

    lead OTHER

Principal Investigators

  • Ignacio Rangel, As.Professor · Örebro University, School of Medical Sciences, Sweden

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-17
Primary Completion
2020-09-18
Completion
2022-06-17

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05446610 on ClinicalTrials.gov